Science Current Events | Science News | Brightsurf.com
 

Tumors Current Events | Tumors News | 11

Sort By: Page Views | Date

Ancient Chinese remedy shows potential in preventing breast cancer
A derivative of the sweet wormwood plant used since ancient times to fight malaria and shown to precisely target and kill cancer cells may someday aid in stopping breast cancer before it gets a toehold.   view more (2005-12-20)

New technique offers relief for patients with spinal tumors
A radiologist at the University of California, San Diego (UCSD) School of Medicine has developed a new procedure to treat fractured vertebrae caused by spinal tumors, a procedure that may decrease the risk of complications, which are experienced by 5 to 10% of patients with malignant tumors of the spine.   view more (2006-05-08)

Effect on Breast Tumors of DNA Alternations in 3 Genes Described
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.   view more (2007-05-17)

New hybrid virus provides targeted molecular imaging of cancer
Researchers at The University of Texas M. D. Anderson Cancer Center have created a new class of hybrid virus and demonstrated its ability to find, highlight, and deliver genes to tumors in mice.   view more (2006-04-24)

Selenium may prevent high risk-bladder cancer
A study published in the December issue of Cancer Prevention Research, a journal of the American Association for Cancer Research, suggests that selenium, a trace mineral found in grains, nuts and meats, may aid in the prevention of high-risk bladder cancer.   view more (2008-12-08)

Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.   view more (2008-07-29)

Cell pathway on overdrive prevents cancer response to dietary restriction
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors are susceptible to dietary restriction during their development.   view more (2009-03-12)

Killing Cancer Like a Vampire Slayer
Like vampires, cancer tumors require an ample supply of blood to stay alive. Without fresh blood for sustenance, cancer cells shrivel up like raisins and die.   view more (2009-09-18)

Cancer drug can extend survival in patients with deadly brain tumors
Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.   view more (2007-02-20)

Preoperative brain mapping alters tumor surgery
By pinpointing the motor and language areas of the brain with functional magnetic resonance imaging (fMRI), surgeons can target brain tumors more effectively while reducing the risk of damaging important cognitive and motor processes, according to a study appearing in the September issue of Radiology.   view more (2006-08-29)

Every moment counts: Predicting treatment responses earlier for brain tumor patients
Using metabolic or molecular imaging to measure brain tumor patients' response to treatment is a powerful predictor of survival, notes a first-of-its-kind study presented at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.   view more (2007-06-04)

Protein holds back growth of head and neck tumors
A protein associated with the growth of head and neck tumors may be a tumor suppressor that could prevent the spread of cancer when it is expressed above normal levels.   view more (2006-02-01)

Molecular imaging holds promise for early intervention in common uterine cancer
A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors.   view more (2009-10-01)

Molecular marker identifies normal stem cells as intestinal tumor source
Scientists at St. Jude Children's Research Hospital have answered a central question in cancer biology: whether normal stem cells can give rise to tumors.   view more (2008-12-18)

Estrogen-Dependent Switch Tempers Killing Activity of Immune Cells
The sex hormone estrogen tempers the killing activity of a specific group of immune cells, the cytotoxic T cells (CTLs), which are known to attack tumor cells and cells infected by viruses.   view more (2009-08-10)

Study shows endoscopic surgery as effective open surgery for nasal cancer
Researchers from Boston University School of Medicine (BUSM) have shown that endoscopic surgery is a valid treatment option for treating esthesioneuroblastoma (cancer of the nasal cavity), in addition to traditional open surgery and nonsurgical treatments.   view more (2009-07-08)

Sequential TACE and cryosurgery can improve survival times for patients with HCC?
Hepatocellular carcinoma (HCC)--a liver cancer--is recognized as one of the most common cancers in the world that disproportionately affects Southeast Asians and Africans.   view more (2009-08-12)

Blood-vessel blocker aids cancer-killing virus
Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly move in and eliminate them.   view more (2007-11-28)

Mayo Clinic finds kidney cancer patients are unlikely to respond to potential treatment drug
Mayo Clinic Cancer Center investigators report that imatinib mesylate (GleevecTM), the drug used to treat patients with gastrointestinal stromal cancers (GISTs), is not likely to be effective for patients with high grade renal cell carcinoma - the most aggressive kidney cancer.   view more (2005-12-22)

New targeted treatment for brain tumors shows promise in pre-clinical models
Monoclonal antibody targets key tumor growth factor; Successfully causes brain tumor regression and improves animal survival.   view more (2006-02-15)
Sort By: Page Views | Date
© 2009 BrightSurf.com